Home/Filings/4/0001178913-23-000076
4//SEC Filing

Mor George Adi 4

Accession 0001178913-23-000076

CIK 0001534248other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:01 PM ET

Size

11.8 KB

Accession

0001178913-23-000076

Insider Transaction Report

Form 4
Period: 2023-01-03
Mor George Adi
DirectorChief Executive Officer10% Owner
Transactions
  • Sale

    American Depositary Shares

    2023-01-03$5.03/sh6,100$30,663251,147 total(indirect: By Spouse)
  • Award

    Option to Purchase American Depositary Shares

    2016-10-28+33,72533,725 total(indirect: By Spouse)
    Exercise: $0.80Exp: 2026-10-27American Depositary Shares (33,725 underlying)
  • Award

    Option to Purchase American Depositary Shares

    2018-03-15+131,698131,698 total
    Exercise: $1.49Exp: 2028-03-15American Depositary Shares (131,698 underlying)
  • Sale

    American Depositary Shares

    2023-01-03$5.03/sh7,700$38,706317,075 total
Footnotes (5)
  • [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
  • [F2]This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022.
  • [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  • [F4]These options have vested and are exercisable as of the date hereof.
  • [F5]These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

Chemomab Therapeutics Ltd.

CIK 0001534248

Entity typeother

Related Parties

1
  • filerCIK 0001851069

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:01 PM ET
Size
11.8 KB